TalkFDA
The Leader in Quality Life Science Training
Register Now
Live Webinar

Continued Process Verification (CPV): Using Review-by-Exception Approaches for Process Monitoring and Product Quality

Clarifies how CPV teams use exception criteria, process trends, and quality evidence to decide when commercial manufacturing data requires action.

Faculty: Meredith L. Crabtree
Session Details
📅
Date
August 14, 2026
🕙
Time
11 AM Eastern Time US/Canada | 3 PM GMT
Duration
90 Minutes
Format
Live + Post-live Continued Access
Register Now

GROUP SAVINGS: Get your team to attend for just $390.

Individual registrations available too.

Course Overview & Structure

Exception criteria determine which CPV signals matter.

CPV teams must decide when commercial manufacturing variation remains expected and when process signals justify investigation, escalation, or quality action.

This session structures exception-based review practices for CPV programs, including thresholds, trend interpretation, emerging risks, and evidence for corrective action.

The session moves from Stage 3 expectations into practical review criteria, then connects process trends, drift indicators, escalation triggers, and quality decision evidence. Examples show how exception-based review can focus attention without reducing confidence in process performance.

WHAT YOU'LL LEARN

Determining When CPV Variation Requires Intervention

  • Stage 3 CPV expectations under FDA Process Validation Guidance
  • Review-by-exception criteria for ongoing process monitoring
  • Thresholds that distinguish expected variability from concern
  • Trend interpretation for commercial process performance
  • Process drift indicators and emerging product quality risks
  • Escalation points for investigation or action
  • Evidence needed to support CPV corrective actions
  • ICH Q10 lifecycle expectations for ongoing verification
Who Should Attend

Designed for professionals responsible for commercial process performance, quality decisions, validation evidence, and ongoing manufacturing control.

Quality Assurance Validation Manufacturing Quality Control Process Engineering MS&T Compliance Regulatory Affairs Quality Systems Technical Management
Meredith L. Crabtree
Course Director

Meredith L. Crabtree

FDA and Quality Expert | Owner - MLKC Consulting, LLC

Meredith Crabtree brings more than 30 years in regulated manufacturing, packaging, labeling, distribution, inspections, recalls, and quality training across pharma, medical device, biologics, laboratory, and related sectors. Her work with quality assessments, consent decree support, and inspection readiness connects directly to CPV decisions involving process evidence, product quality, and ongoing control.

FDB1614
After You Register

Everything related to your course lives in one place.

01

You receive confirmation and the course appears in your TalkFDA dashboard.

02

Your course page becomes the hub for joining the session and accessing materials.

03

At the scheduled time, click Join Session to enter the live Webex session.

04

After the session, playback becomes available on the same course page.

05

Complete the course and your certificate is unlocked in your learning history.

For Teams Seeking Deeper Implementation Support

Customized training is also available through TalkFDA Elite Training Labs.

This topic can also be delivered as a customized session for organizations seeking structured, implementation-focused training aligned with their internal processes and quality systems.

TalkFDA Elite Training Labs

Continued Process Verification (CPV):

Using Review-by-Exception Approaches for Process Monitoring and Product Quality

📅 August 14, 2026 🕛 11 AM Eastern Time US/Canada | 3 PM GMT
Register Now